title: Ocrelizumab in multiple sclerosis: risks and benefits.
authors.forename: Abhijit
authors.initials: A
authors.lastname: Chaudhuri
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized